Literature DB >> 21107342

Cyclin D1 rare variants in UK multiple adenoma and early-onset colorectal cancer patients.

Carolina Bonilla1, Jérémie H Lefèvre, Bruce Winney, Elaine Johnstone, Susan Tonks, Chrystelle Colas, Tammy Day, Katarzyna Hutnik, Abdelhamid Boumertit, Rachel Midgley, David Kerr, Yann Parc, Walter F Bodmer.   

Abstract

We examined the influence that rare variants and low-frequency polymorphisms in the cancer candidate gene CCND1 have on the development of multiple intestinal adenomas and the early onset of colorectal cancer. Individuals with <100 multiple polyps and patients with colorectal cancer diagnosed before 50 years of age were recruited in UK, and screened for sequence changes in the coding and regulatory regions of CCND1. A set of about 800 UK control individuals was genotyped for the variants discovered in the cases. Variants in the promoter, intron-exon boundaries and untranslated regions of the CCND1 gene had higher frequencies in cases than in controls. Five of these variants were typed in a set of French multiple adenoma and early-onset patients, who also showed higher allele frequencies than UK controls. When pooled together, variants with frequencies lower than 1% conferred an increased risk of disease that was significant in the multiple adenoma group (odds ratio (OR) 2.2; 95% confidence interval, 1.1-4.4; P = 0.03). Most variants had a putative functional effect when assessed in silico. We conclude that rare variants of CCND1 are risk factors for colorectal cancer, with considerably larger effects than common polymorphisms, and as such should be systematically evaluated in susceptibility studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107342      PMCID: PMC5140020          DOI: 10.1038/jhg.2010.144

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  48 in total

Review 1.  The allelic architecture of human disease genes: common disease-common variant...or not?

Authors:  Jonathan K Pritchard; Nancy J Cox
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

Review 2.  Lost in the space of bioinformatic tools: a constantly updated survival guide for genetic epidemiology. The GenEpi Toolbox.

Authors:  Stefan Coassin; Anita Brandstätter; Florian Kronenberg
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

3.  Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.

Authors:  Thorsten Bartusel; Stephan Schubert; Karl-Heinz Klempnauer
Journal:  Gene       Date:  2005-05-23       Impact factor: 3.688

4.  Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer.

Authors:  S Kong; C I Amos; R Luthra; P M Lynch; B Levin; M L Frazier
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

5.  CYCLIN D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer.

Authors:  S Bala; P Peltomäki
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

6.  A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia.

Authors:  Y Hosokawa; R Suzuki; T Joh; Y Maeda; S Nakamura; Y Kodera; A Arnold; M Seto
Journal:  Int J Cancer       Date:  1998-06-10       Impact factor: 7.396

7.  Aurora-A and Cyclin D1 polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer.

Authors:  Bente A Talseth; Katie A Ashton; Cliff Meldrum; Janina Suchy; Grzegorz Kurzawski; Jan Lubinski; Rodney J Scott
Journal:  Int J Cancer       Date:  2008-03-15       Impact factor: 7.396

8.  CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.

Authors:  K M Sathyan; K R Nalinakumari; Thomas Abraham; S Kannan
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

9.  3'UTR mediated regulation of the cyclin D1 proto-oncogene.

Authors:  Anagha Deshpande; Alessandro Pastore; Aniruddha J Deshpande; Yvonne Zimmermann; Grit Hutter; Marc Weinkauf; Christian Buske; Wolfgang Hiddemann; Martin Dreyling
Journal:  Cell Cycle       Date:  2009-11-03       Impact factor: 4.534

10.  The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.

Authors:  Katie A Ashton; Anthony Proietto; Geoffrey Otton; Ian Symonds; Mark McEvoy; John Attia; Michael Gilbert; Ute Hamann; Rodney J Scott
Journal:  BMC Cancer       Date:  2008-09-29       Impact factor: 4.430

View more
  7 in total

Review 1.  Early-onset colorectal cancer: a sporadic or inherited disease?

Authors:  Vittoria Stigliano; Lupe Sanchez-Mete; Aline Martayan; Marcello Anti
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Cyclin D1b overexpression inhibits cell proliferation and induces cell apoptosis in cervical cancer cells in vitro and in vivo.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Di Jiang; Yan Jiang; Shulan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  Role of rare variants in undetermined multiple adenomatous polyposis and early-onset colorectal cancer.

Authors:  Jérémie H Lefevre; Carolina Bonilla; Chrystelle Colas; Bruce Winney; Elaine Johnstone; Susan Tonks; Tammy Day; Katarzyna Hutnik; Abdelhamid Boumertit; Florent Soubrier; Rachel Midgley; David Kerr; Yann Parc; Walter F Bodmer
Journal:  J Hum Genet       Date:  2012-08-09       Impact factor: 3.172

Review 4.  Colorectal Cancer in the Young.

Authors:  Swati G Patel; Dennis J Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

5.  Expression Of Cyclin D1 Protein Isoforms And Its Prognostic Significance In Cervical Cancer.

Authors:  Jiahui Gu; Xinyu Zhang; Zhuo Yang; Ning Wang
Journal:  Cancer Manag Res       Date:  2019-10-24       Impact factor: 3.989

6.  CCND1 gene polymorphic variants in patients with differentiated thyroid carcinoma.

Authors:  Szymon Hryhorowicz; Katarzyna Ziemnicka; Marta Kaczmarek-Ryś; Justyna Hoppe-Gołębiewska; Andrzej Pławski; Marzena Skrzypczak-Zielińska; Małgorzata Szkudlarek; Monika Gołąb; Bartłomiej Budny; Marek Ruchała; Ryszard Słomski
Journal:  Oncol Lett       Date:  2014-10-15       Impact factor: 2.967

7.  ≤ Cyclin D1 protein affecting global women's health by regulating HPV mediated adenocarcinoma of the uterine cervix.

Authors:  Richa Tripathi; Gayatri Rath; Poonam Jawanjal; Mausumi Bharadwaj; Ravi Mehrotra
Journal:  Sci Rep       Date:  2019-03-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.